Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Aripiprazole prolonged-release suspension for injection

Brand: Abilify Maintena®
NICE TA: 
Indication: Maintenance treatment of schizophrenia in adult patients
Disease category: Central nervous system
Commissioning responsibility: CCG
PbR excluded: No

Background

Aripiprazole prolonged-release (PR) suspension for injection is recommended as a treatment option in the maintenance treatment of schizophrenia in adult patients stabilised with oral aripiprazole where both of the following criteria are met;
• where treatment is in line with the recommendations within NICE CG178 for the use of depot or long-acting injectable antipsychotic medication and
• where treatment is in line with the Lancashire Care Guidance for Prescribing Second Generation Long Acting Antipsychotic Injections

Recommendation

LMMG recommendation: Red
Click here to find the definitions for the colour classifications

Reason for decision:  Specialist medicine

Supporting documents:

Guidance For Prescribing Second Generation Long Acting Antipsychotic Injections (608.9 KiB)

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Red

Red

Red

Red

Red

Red